CDT ENVIRONMENTAL TECHNOLOGY (CDTG) Stock Fundamental Analysis

NASDAQ:CDTG • KYG2030P1072

0.232 USD
+0 (+0.3%)
Last: Feb 25, 2026, 08:00 PM
Fundamental Rating

3

Taking everything into account, CDTG scores 3 out of 10 in our fundamental rating. CDTG was compared to 80 industry peers in the Commercial Services & Supplies industry. CDTG has a medium profitability rating, but doesn't score so well on its financial health evaluation. CDTG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year CDTG was profitable.
  • In the past year CDTG has reported a negative cash flow from operations.
CDTG Yearly Net Income VS EBIT VS OCF VS FCFCDTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

  • The Return On Assets of CDTG (3.27%) is better than 67.50% of its industry peers.
  • With a decent Return On Equity value of 7.84%, CDTG is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.04%, CDTG is in the better half of the industry, outperforming 66.25% of the companies in the same industry.
  • CDTG had an Average Return On Invested Capital over the past 3 years of 12.17%. This is in line with the industry average of 10.62%.
  • The last Return On Invested Capital (7.04%) for CDTG is well below the 3 year average (12.17%), which needs to be investigated, but indicates that CDTG had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.27%
ROE 7.84%
ROIC 7.04%
ROA(3y)7.51%
ROA(5y)N/A
ROE(3y)16.76%
ROE(5y)N/A
ROIC(3y)12.17%
ROIC(5y)N/A
CDTG Yearly ROA, ROE, ROICCDTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

  • CDTG has a Profit Margin of 6.88%. This is in the better half of the industry: CDTG outperforms 76.25% of its industry peers.
  • In the last couple of years the Profit Margin of CDTG has declined.
  • CDTG's Operating Margin of 9.02% is fine compared to the rest of the industry. CDTG outperforms 65.00% of its industry peers.
  • CDTG's Operating Margin has declined in the last couple of years.
  • CDTG's Gross Margin of 37.10% is fine compared to the rest of the industry. CDTG outperforms 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of CDTG has grown nicely.
Industry RankSector Rank
OM 9.02%
PM (TTM) 6.88%
GM 37.1%
OM growth 3Y-40.86%
OM growth 5YN/A
PM growth 3Y-44.63%
PM growth 5YN/A
GM growth 3Y1.57%
GM growth 5YN/A
CDTG Yearly Profit, Operating, Gross MarginsCDTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

  • CDTG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CDTG has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CDTG has been reduced compared to a year ago.
CDTG Yearly Shares OutstandingCDTG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
CDTG Yearly Total Debt VS Total AssetsCDTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of 1.44, we must say that CDTG is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.44, CDTG is not doing good in the industry: 63.75% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.15 indicates that CDTG is not too dependend on debt financing.
  • The Debt to Equity ratio of CDTG (0.15) is better than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACC1.34
WACC5.27%
CDTG Yearly LT Debt VS Equity VS FCFCDTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • CDTG has a Current Ratio of 1.50. This is a normal value and indicates that CDTG is financially healthy and should not expect problems in meeting its short term obligations.
  • CDTG has a Current ratio (1.50) which is comparable to the rest of the industry.
  • CDTG has a Quick Ratio of 1.50. This is a normal value and indicates that CDTG is financially healthy and should not expect problems in meeting its short term obligations.
  • CDTG has a Quick ratio of 1.50. This is comparable to the rest of the industry: CDTG outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
CDTG Yearly Current Assets VS Current LiabilitesCDTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

  • CDTG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.11%.
  • CDTG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -39.42% yearly.
  • Looking at the last year, CDTG shows a very negative growth in Revenue. The Revenue has decreased by -14.54% in the last year.
  • The Revenue has been growing by 8.11% on average over the past years. This is quite good.
EPS 1Y (TTM)-67.11%
EPS 3Y-39.42%
EPS 5YN/A
EPS Q2Q%-79.69%
Revenue 1Y (TTM)-14.54%
Revenue growth 3Y8.11%
Revenue growth 5YN/A
Sales Q2Q%-12.99%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CDTG Yearly Revenue VS EstimatesCDTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 0.80, the valuation of CDTG can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than CDTG, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CDTG to the average of the S&P500 Index (27.05), we can say CDTG is valued rather cheaply.
Industry RankSector Rank
PE 0.8
Fwd PE N/A
CDTG Price Earnings VS Forward Price EarningsCDTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than CDTG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.72
CDTG Per share dataCDTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for CDTG!.
Industry RankSector Rank
Dividend Yield 0%

CDT ENVIRONMENTAL TECHNOLOGY

NASDAQ:CDTG (2/25/2026, 8:00:02 PM)

0.232

+0 (+0.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.46%
Inst Owner Change-59.85%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.86M
Revenue(TTM)42.45M
Net Income(TTM)2.92M
AnalystsN/A
Price TargetN/A
Short Float %0.22%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.8
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.08
P/tB 0.08
EV/EBITDA 0.72
EPS(TTM)0.29
EY125%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS3.45
BVpS3.03
TBVpS3.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.44
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 7.84%
ROCE 10.17%
ROIC 7.04%
ROICexc 7.06%
ROICexgc 7.07%
OM 9.02%
PM (TTM) 6.88%
GM 37.1%
FCFM N/A
ROA(3y)7.51%
ROA(5y)N/A
ROE(3y)16.76%
ROE(5y)N/A
ROIC(3y)12.17%
ROIC(5y)N/A
ROICexc(3y)12.25%
ROICexc(5y)N/A
ROICexgc(3y)12.26%
ROICexgc(5y)N/A
ROCE(3y)18.86%
ROCE(5y)N/A
ROICexgc growth 3Y-47.84%
ROICexgc growth 5YN/A
ROICexc growth 3Y-47.84%
ROICexc growth 5YN/A
OM growth 3Y-40.86%
OM growth 5YN/A
PM growth 3Y-44.63%
PM growth 5YN/A
GM growth 3Y1.57%
GM growth 5YN/A
F-Score2
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr 1.42%
Cap/Sales 0.01%
Interest Coverage 27.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z 1.44
F-Score2
WACC5.27%
ROIC/WACC1.34
Cap/Depr(3y)9.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.13%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.11%
EPS 3Y-39.42%
EPS 5YN/A
EPS Q2Q%-79.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.54%
Revenue growth 3Y8.11%
Revenue growth 5YN/A
Sales Q2Q%-12.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.07%
EBIT growth 3Y-36.07%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.57%
OCF growth 3YN/A
OCF growth 5YN/A

CDT ENVIRONMENTAL TECHNOLOGY / CDTG FAQ

Can you provide the ChartMill fundamental rating for CDT ENVIRONMENTAL TECHNOLOGY?

ChartMill assigns a fundamental rating of 3 / 10 to CDTG.


What is the valuation status of CDT ENVIRONMENTAL TECHNOLOGY (CDTG) stock?

ChartMill assigns a valuation rating of 3 / 10 to CDT ENVIRONMENTAL TECHNOLOGY (CDTG). This can be considered as Overvalued.


What is the profitability of CDTG stock?

CDT ENVIRONMENTAL TECHNOLOGY (CDTG) has a profitability rating of 5 / 10.